Share on Facebook
The Commission has launched a selection procedure to appoint Civil Society representatives in the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency. One representative of patients' organisation and one alternate will be appointed.
Created: 2022-01-14 12:42:21
Category: Public Health
Today the Commission has adopted the second EU4Health work programme. In 2022, the EU4Health will co...
Created: 2022-01-12 12:40:04
Category: Public Health
Funding
European Health and Digital Executive Agency (HaDEA) publishes a call for tenders - Service...